While there is conflicting evidence regarding ACPA status and response to therapy, the comparative analysis of peripheral blood and importantly, synovial tissue T cell cytokine responses of ACPA− and ACPA+ RA patients, might allow the development of RA endotype specific treatment strategies [27]. Here, PRTN3 is linked to rheumatoid arthritis.